Skip to main content
. Author manuscript; available in PMC: 2017 Jun 15.
Published in final edited form as: Breast Cancer Res Treat. 2012 Sep 23;136(1):169–178. doi: 10.1007/s10549-012-2256-5

Table 3.

Best Response by RECIST (n = 20 evaluable)

No. of patients (%)
Complete response      (0)
Partial response   2 (10 %)
Stable disease 13 (65 %)
Stable disease ≥4 months   5 (25 %)
Stable disease ≥6 months   3 (15 %)
Progressive disease   5 (25 %)